Neurologic Imaging

What Is the Best Initial Imaging for Secondary Hyperparathyroidism? An ACR-Guided Workflow

·
What Is the Best Initial Imaging for Secondary Hyperparathyroidism? An ACR-Guided Workflow

A patient with end-stage renal disease on hemodialysis presents for routine follow-up. Despite optimized medical therapy including phosphate binders and vitamin D analogues, their parathyroid hormone (PTH) level remains persistently and severely elevated, consistent with refractory secondary hyperparathyroidism. The nephrology and surgical teams are now considering a parathyroidectomy to manage the patient’s renal osteodystrophy and cardiovascular risk. As the ordering clinician, you must decide on the best initial imaging study to localize the hyperplastic glands and guide the surgeon. This article details the American College of Radiology (ACR) Appropriateness Criteria for this specific scenario, explaining why a particular study is the preferred first step. For the initial imaging of secondary hyperparathyroidism, the ACR rates US parathyroid as Usually Appropriate.

Who Fits This Clinical Scenario for Secondary Hyperparathyroidism Imaging?

This guidance applies to both adult and pediatric patients with a confirmed biochemical diagnosis of secondary hyperparathyroidism who are undergoing their initial imaging workup. The classic patient profile is an individual with chronic kidney disease (CKD), particularly those on dialysis, where impaired phosphate excretion and reduced active vitamin D synthesis lead to a compensatory, reactive overproduction of PTH from all parathyroid glands. However, the scenario also includes patients with other causes of chronic hypocalcemia, such as severe vitamin D deficiency or malabsorption syndromes.

The key distinction is that the parathyroid glands are responding to an external stimulus, leading to multiglandular hyperplasia, rather than autonomously overproducing hormone from a primary tumor.

It is critical to distinguish this presentation from related but distinct clinical scenarios that follow different diagnostic pathways:

  • Primary Hyperparathyroidism: This involves the autonomous overproduction of PTH, most commonly from a single parathyroid adenoma. The imaging goal is to pinpoint one culprit gland, which is a different task than mapping four hyperplastic glands.
  • Tertiary Hyperparathyroidism: This condition arises after a long period of secondary hyperparathyroidism, where the hyperplastic glands become autonomous and no longer respond to medical therapy or even a kidney transplant. While the underlying pathophysiology is related, the imaging approach may differ.
  • Recurrent or Persistent Hyperparathyroidism After Surgery: A patient who has already undergone a parathyroidectomy and has persistently high PTH levels requires a more complex workup, as scar tissue and altered anatomy make localization significantly more challenging. This is a separate ACR variant.

Applying this workflow to the wrong clinical context can lead to suboptimal study selection and interpretation.

What Are You Looking For? The Anatomic Correlates of Secondary Hyperparathyroidism

Unlike primary hyperparathyroidism, where the search is typically for a single adenoma, the imaging goal in secondary hyperparathyroidism is to evaluate diffuse glandular changes. The differential for the imaging findings is centered on the expected pathophysiology of the disease.

The primary finding you are working to identify is four-gland parathyroid hyperplasia. In this state, all parathyroid glands become enlarged and hypercellular in response to chronic stimulation. The goal of imaging is to confirm the presence of enlarged glands, document their location relative to the thyroid and other neck structures, and measure their size. This information is crucial for the surgeon planning a subtotal parathyroidectomy (removing 3.5 glands) or a total parathyroidectomy with autotransplantation.

Another key consideration is identifying any asymmetrically enlarged or dominant glands. While all glands are hyperplastic, one or two may grow significantly larger than the others. Identifying these dominant glands can help the surgeon ensure they are removed.

Imaging also serves to locate ectopic parathyroid glands. While the majority of people have four glands in the typical locations posterior to the thyroid, some have supernumerary glands (five or six) or glands located in atypical, ectopic positions, such as the thymus, mediastinum, or even within the thyroid gland itself. Failure to identify and remove an ectopic gland is a common cause of persistent disease after surgery.

Finally, imaging helps differentiate parathyroid tissue from thyroid nodules and other neck pathology, which are common incidental findings and can mimic an enlarged parathyroid gland.

Why Is Parathyroid Ultrasound the Recommended First Study for Secondary Hyperparathyroidism?

The ACR designates US parathyroid as a Usually Appropriate initial imaging test for secondary hyperparathyroidism. This recommendation is based on its excellent safety profile, high spatial resolution for cervical structures, and lack of ionizing radiation.

The primary rationale for choosing ultrasound first is its risk-benefit profile, especially in the CKD population.

  • Safety: Ultrasound uses no ionizing radiation (adult and pediatric radiation relative level: O, 0 mSv) and does not require intravenous contrast. This avoids the risks of contrast-induced nephropathy in patients with residual kidney function and the rare but serious risk of nephrogenic systemic fibrosis associated with gadolinium-based contrast agents in MRI.
  • Anatomic Detail: High-frequency ultrasound provides superb spatial resolution of the soft tissues of the neck. It can readily identify enlarged, hypoechoic parathyroid glands, measure their dimensions accurately, and map their relationship to the thyroid gland, trachea, and major vessels. It is also highly effective at distinguishing parathyroid tissue from thyroid nodules or lymph nodes.
  • Accessibility and Cost: Ultrasound is widely available, relatively inexpensive, and can be performed quickly without extensive patient preparation.

While ultrasound is the preferred starting point, other modalities are also rated highly but come with specific trade-offs, making them better suited as second-line or complementary studies in this scenario:

  • Sestamibi Dual-Phase Scan with SPECT/CT: This nuclear medicine study is also rated Usually Appropriate. It provides functional information by identifying hypermetabolic parathyroid tissue. Its main advantage over ultrasound is the ability to detect ectopic glands in the chest (mediastinum), which are beyond the field of view of a neck ultrasound. However, it involves ionizing radiation (RRL: ☢☢☢ 1-10 mSv) and may show diffuse uptake in all glands, making it less precise for localizing individual glands in the neck compared to ultrasound.
  • CT Neck Without and With IV Contrast: Also rated Usually Appropriate, this study offers excellent cross-sectional anatomic detail. However, it exposes the patient to significant ionizing radiation (RRL: ☢☢☢ 1-10 mSv) and requires IV contrast, which is a major consideration in patients with CKD. For these reasons, it is typically reserved for cases where ultrasound and/or sestamibi are non-localizing.

What Is the Downstream Workflow After a Parathyroid Ultrasound?

The results of the initial parathyroid ultrasound directly guide the next steps in management, which almost always involve a conversation with the endocrine surgeon.

  • If the ultrasound is positive and localizes all enlarged glands: When the ultrasound successfully identifies four (or more) enlarged glands in the neck consistent with hyperplasia, this information may be sufficient for surgical planning. The surgeon can proceed with a planned bilateral neck exploration and subtotal or total parathyroidectomy.
  • If the ultrasound is negative or equivocal: It is not uncommon for ultrasound to fail to visualize all hyperplastic glands, especially if they are small, located deep in the neck, or positioned ectopically (e.g., retroesophageal). In this situation, the next logical step is to order a functional imaging study. A Sestamibi dual-phase scan with SPECT or SPECT/CT is the most common choice to detect metabolically active ectopic tissue, particularly in the mediastinum.
  • If both ultrasound and sestamibi are non-localizing: If both initial studies fail to localize the glands, but the biochemical diagnosis is strong, the patient may still be a candidate for surgery. The surgeon, however, will be prepared for a more extensive and challenging bilateral neck exploration. In select, complex cases of persistent or recurrent disease after initial surgery (a different clinical scenario), advanced imaging like 4D-CT or MRI may be considered, but these are not typically part of the initial workup.

The ultimate decision to proceed to surgery is based on the severity of the biochemical abnormalities and clinical symptoms, not solely on the ability of imaging to preoperatively localize the glands.

Pitfalls to Avoid (and When to Get Help)

When ordering and interpreting imaging for secondary hyperparathyroidism, several common pitfalls can compromise the diagnostic workflow:

  • Mistaking the Indication: Do not use the primary hyperparathyroidism imaging algorithm (searching for a single adenoma) for a patient with secondary disease (mapping multiglandular hyperplasia). The pre-test probability and imaging goals are different.
  • Stopping with a Negative Ultrasound: A negative or incomplete ultrasound does not rule out the diagnosis. Given the high likelihood of ectopic or deep glands, a negative initial study should prompt consideration of a second, complementary modality like a sestamibi scan.
  • Ignoring the CKD Context: Prioritizing non-contrast and non-radiation modalities like ultrasound is crucial in the CKD population. Avoid ordering contrast-enhanced CT or MRI as a first-line test without a compelling reason.
  • Incomplete Communication: Ensure the radiologist or nuclear medicine physician is aware of the specific clinical question. Stating “secondary hyperparathyroidism, pre-operative planning” on the order provides critical context that distinguishes it from a search for a single adenoma.

If initial non-invasive imaging is unrevealing and the surgical plan is unclear, escalation to a multidisciplinary conference with endocrinology, nephrology, surgery, and radiology is the most appropriate next step.

Related ACR Topics and Tools

This article covers one specific variant within the broader topic of parathyroid imaging. For a comprehensive overview of other clinical scenarios, such as primary or tertiary hyperparathyroidism, please consult our parent guide. For additional resources on imaging selection, technique, and safety, the following tools are available.

Frequently Asked Questions

Why is ultrasound preferred over a Sestamibi scan as the very first test for secondary hyperparathyroidism?

Ultrasound is preferred as the initial test primarily due to its safety profile. It involves no ionizing radiation and no intravenous contrast, which are important considerations in patients with chronic kidney disease. While Sestamibi scans are also rated ‘Usually Appropriate,’ they involve radiation and are often better suited as a second-line test to find ectopic glands if ultrasound is non-localizing.

What if the patient has a contraindication to ultrasound, like a tracheostomy or extensive neck scarring?

In cases where an adequate ultrasound examination is not feasible, it is appropriate to proceed directly to a Sestamibi scan with SPECT/CT as the initial imaging study. This provides both functional and anatomic information and can visualize glands in the neck and chest.

Does this guidance apply to children with secondary hyperparathyroidism?

Yes, the ACR scenario explicitly includes both adults and children. The principle of minimizing ionizing radiation is even more critical in pediatric patients, further strengthening the recommendation to start with a radiation-free modality like ultrasound.

If all four glands are expected to be enlarged, what is the point of imaging before surgery?

Preoperative imaging serves several key purposes: it confirms the presence and location of enlarged glands, helps identify any ectopic glands (especially in the chest, if Sestamibi is used) that would be missed during a standard neck exploration, and differentiates parathyroid glands from other neck structures like thyroid nodules or lymph nodes. This information helps the surgeon plan the extent of the operation and minimize surgical time and complications.

Is 4D-CT ever used for an initial workup of secondary hyperparathyroidism?

No, 4D-CT is generally not recommended for the *initial* imaging workup of secondary hyperparathyroidism. It is a high-radiation, contrast-enhanced study typically reserved for complex cases, such as localizing a culprit gland in recurrent or persistent hyperparathyroidism after a previous surgery, where scar tissue and altered anatomy make other tests difficult.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026